{"uuid": "2e80ea1b-ff80-42b8-a783-ecd6489f2537", "vulnerability_lookup_origin": "1a89b78e-f703-45f3-bb86-59eb712668bd", "author": "2a075640-a300-48a4-bb44-bc6130783b9b", "vulnerability": "CVE-2025-0416", "type": "seen", "source": "https://t.me/cvedetector/21705", "content": "{\n  \"Source\": \"CVE FEED\",\n  \"Title\": \"CVE-2025-0416 - Valmet DNA DCOM Privilege Escalation Vulnerability\", \n  \"Content\": \"CVE ID : CVE-2025-0416 \nPublished : April 1, 2025, 4:15 a.m. | 1\u00a0hour, 1\u00a0minute ago \nDescription : Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023.\u00a0The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system. \nSeverity: 0.0 | NA \nVisit the link for more details, such as CVSS details, affected products, timeline, and more...\",\n  \"Detection Date\": \"01 Apr 2025\",\n  \"Type\": \"Vulnerability\"\n}\n\ud83d\udd39 t.me/cvedetector \ud83d\udd39", "creation_timestamp": "2025-04-01T07:45:59.000000Z"}